Refine
Year of publication
Document Type
Way of publication
- Open Access (12)
Keywords
- Arthrospira platensis (6)
- Genotoxicity (4)
- COVID-19 (3)
- Pyrrolizidine alkaloids (3)
- endothelial cells (3)
- CPR (2)
- CYP3A4 (2)
- Cytotoxicity (2)
- HepG2 (2)
- Liver cells (2)
- Primary human hepatocytes (2)
- Spirulina (2)
- cancer (2)
- cytochrome P450 monooxygenase (2)
- fibroblasts (2)
- fibrosis (2)
- liver (2)
- morphology (2)
- p53 (2)
- temperature (2)
- γH2AX (2)
- ABC transporter (1)
- Acrolein (1)
- Aneuploidy (1)
- Atmospheric CO2 (1)
- Autoimmune disease (1)
- Benchmark dose modeling (1)
- Biocatalysis (1)
- Biomass production (1)
- Biophysics (1)
- Biotechnology (1)
- CHO-K1 (1)
- CYP (1)
- CYP1A2 (1)
- CYP450 (1)
- Carbon capturing (1)
- Carcinogenicity (1)
- Cardiovascular implants (1)
- Cell biology (1)
- Chinese hamster ovary cells (1)
- Climate change (1)
- Corona virus (1)
- Cyclophosphamide (1)
- Cytochrome P450 (1)
- DNA adducts (1)
- DNA damage (1)
- DPI (1)
- Decarbonization (1)
- Drug discovery (1)
- Erythrocytes (1)
- Estragole (1)
- FPLC (1)
- Germany (1)
- HIV (1)
- HUVEC (1)
- HepG2-CYP3A4 (1)
- Hepatoma (1)
- Human drug metabolites (1)
- Human umbilical venous endothelial cells (1)
- IMAC (1)
- Liver biotransformation (1)
- Liver metabolism (1)
- MG-132 (1)
- Ma2 (1)
- Microbiome (1)
- Micronuclei (1)
- Multidisciplinary (1)
- Mutagenicity (1)
- NADPH P450 oxidoreductase (1)
- NADPH-cytochrome P450 oxidoreductase (1)
- OCT1 (1)
- PNMA2 (1)
- PNS (1)
- POR (1)
- Peroxygenase (1)
- Phase-1 (1)
- Potency ranking (1)
- RNA sequencing (1)
- Relative potencies (1)
- SARS-CoV-2 (1)
- Sweden (1)
- T7 expression system (1)
- Taiwan (1)
- Toxicity (1)
- Transport (1)
- actin (1)
- adherent (1)
- aging (1)
- animal feeding (1)
- arterial endothelial cells (1)
- atherosclerosis (1)
- atrial fibrillation (1)
- autoantibodies (1)
- bioreactor (1)
- biotransformation (1)
- cancer cells (1)
- cardiovascular disease (1)
- cell culture (1)
- cell lines (1)
- cyclophosphamide (1)
- cytochrome P450 (1)
- cytochrome P450 enzyme (1)
- cytochrome P450 enzymes (CYP) (1)
- cytotoxicity (1)
- dietary supplements (1)
- diphenyleneiodonium (1)
- donor variability (1)
- dot blot immunoassay (1)
- drug-drug interaction (1)
- echinocytes (1)
- ecotoxicity (1)
- endocytosis (1)
- endothelial cell dysfunction (1)
- endotheliitis (1)
- ensartinib (1)
- first-pass effect (1)
- fission (1)
- fluorescence (1)
- fragmentation (1)
- growth (1)
- hammer and dance strategy (1)
- health effects (1)
- heart (1)
- hepatocytes (1)
- hepatotoxicity (1)
- herd immunity (1)
- human umbilical vein endothelial cells (1)
- human venous endothelial cells (1)
- in vitro culture systems (1)
- in vitro study (1)
- influencing factors (1)
- life cycle (1)
- light intensity (1)
- light stress (1)
- liver protection (1)
- mediator release (1)
- mesalamine (1)
- microplastic (1)
- multidrug resistance (1)
- non-adherent (1)
- nutrition (1)
- osteopontin (1)
- phase-1 biotransformation (1)
- photoinhibition (1)
- phototoxicity (1)
- platelets (1)
- senescence (1)
- serum-free (1)
- spirulina (1)
- spirulina platensis (1)
- strategy (1)
- submembraneous cytoskeleton (1)
- suspension cells (1)
- thrombosis (1)
- trimethylamin-N-oxide (1)
- viability (1)
- virus infection (1)
- von Willebrand factor (1)
- wave length (1)
- xCELLigence system (1)
Institute
BTU
Paraneoplastic neurological syndromes (PNS) are caused by an immune response against neuronal proteins upon their ectopical expression in tumor cells. Ma2 belongs to the protein family of paraneoplastic Ma antigens (PNMA). Detection of Ma2-specific autoantibodies is relevant for diagnostics of anti-Ma2 PNS and an underlying tumor such as germ testicular cancer, small cell lung cancer or breast cancer. Thus, early tumor treatment should improve the outcome for PNS therapy either.
Dot blot immunoassay based on recombinantly expressed and purified autoantigens could offer a sensitive method for identification of paraneoplastic autoantibodies from sera of PNS patients. Here we present purification with IMAC and FPLC of human Ma2 autoantigen upon its recombinant expression in E.coli. Furthermore, we provide evidence that dot blot immunoassays with purified Ma2 autoantigen can be used for detection of Ma2-specific autoantibodies from sera of PNS patients.
Estragole is a natural constituent in herbs and spices and in products thereof such as essential oils or herbal teas. After cytochrome P450-catalyzed hydroxylation and subsequent sulfation, estragole acts as a genotoxic hepatocarcinogen forming DNA adducts in rodent liver. Because of the genotoxic mode of action and the widespread occurrence in food and phytomedicines a refined risk assessment for estragole is needed. We analyzed the time- and concentration-dependent levels of the DNA adducts N2-(isoestragole-3‘-yl)-2‘-desoxyguanosine (E3′N2dG) and N6-(isoestragole-3‘-yl)-desoxyadenosine (E3′N6dA), reported to be the major adducts formed in rat liver, in rat hepatocytes (pRH) in primary culture after incubation with estragole. DNA adduct levels were measured via UHPLC-ESI-MS/MS using stable isotope dilution analysis. Both adducts were formed in pRH and could already be quantified after an incubation time of 1 h (E3′N6dA at 10 μM, E3′N2dG at 1μM estragole). E3′N2dG, the main adduct at all incubation times and concentrations, could be detected at estragole concentrations < 0.1 μM after 24 h and < 0.5 μM after 48 h. Adduct levels were highest after 6 h and showed a downward trend at later time-points, possibly due to DNA repair and/or apoptosis. While the concentration-response characteristics of adduct formation were apparently linear over the whole concentration range, strong indication for marked hypo-linearity was obtained when the modeling was based on concentrations < 1 μM only. In the micronucleus assay no mutagenic potential of estragole was found in HepG2 cells whereas in HepG2-CYP1A2 cells 1 μM estragole led to a 3.2 fold and 300 μM to a 7.1 fold increase in micronuclei counts. Our findings suggest the existence of a ‘practical threshold’ dose for DNA adduct formation as an initiating key event of the carcinogenicity of estragole indicating that the default assumption of concentration-response-linearity is questionable, at least for the two major adducts studied here.
1,2-unsaturated pyrrolizidine alkaloids (PAs) are natural plant constituents comprising more than 600 different structures. A major source of human exposure is thought to be cross-contamination of food, feed and phytomedicines with PA plants. In humans, laboratory and farm animals, certain PAs exert pronounced liver toxicity and can induce malignant liver tumors in rodents. Here, we investigated the cytotoxicity and genotoxicity of eleven PAs belonging to different structural classes. Although all PAs were negative in the fluctuation Ames test in Salmonella, they were cytotoxic and induced micronuclei in human HepG2 hepatoblastoma cells over-expressing human cytochrome P450 3A4. Lasiocarpine and cyclic diesters except monocrotaline were the most potent congeners both in cytotoxicity and micronucleus assays with concentrations below 3 μM inducing a doubling in micronuclei counts. Other open di-esters and all monoesters exhibited weaker or much weaker geno- and cytotoxicity. The findings were in agreement with recently suggested interim Relative Potency (iREP) factors with the exceptions of europine and monocrotaline. A more detailed micronuclei analysis at low concentrations of lasiocarpine, retrorsine or senecionine indicated that pronounced hypolinearity of the concentration–response curves was evident for retrorsine and senecionine but not for lasiocarpine. Our findings show that the genotoxic and cytotoxic potencies of PAs in a human hepatic cell line vary in a structure-dependent manner. Both the low potency of monoesters and the shape of prototype concentration–response relationships warrant a substance- and structure-specific approach in the risk assessment of PAs.
Atrial fibrillation (AF) is regularly accompanied by cardiac fibrosis and concomitant heart failure. Due to the heterogeneous nature and complexity of fibrosis, the knowledge about the underlying mechanisms is limited, which prevents effective pharmacotherapy. A deeper understanding of cardiac fibroblasts is essential to meet this need. We previously described phenotypic and functional differences between atrial fibroblasts from patients in sinus rhythm and with AF. Herein, we established and characterized a novel human atrial fibroblast line, which displays typical fibroblast morphology and function comparable to primary cells but with improved proliferation capacity and low spontaneous myofibroblast differentiation. These traits make our model suitable for the study of fibrosis mechanisms and for drug screening aimed at developing effective antifibrotic pharmacotherapy.
COVID-19 and the endothelium
(2020)
There is growing evidence that COVID-19 not only affects the lungs but beyond that the endothelial system. Recent studies showed that this can lead to microcirculatory impairments and in consequence to functional disorders of all inner organs. The combination of endothelial dysfunction with a generalized inflammatory state and complement elements may together contribute to the overall pro-coagulative state described in COVID-19 patients leading to venular as well as to arteriolar occlusions.
Some months ago, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, China, and spread rapidly around the world. Some states, such as the Netherlands, Germany, Great Britain, Sweden and the USA initially focused on keeping the restrictions for economy and society as low as possible. The responsible authorities were of the opinion - and still are e.g. in Sweden - that it is sufficient enough to protect particularly vulnerable persons such as the elderly or people with pre-existing conditions. The idea behind this is that as soon as 60 to 70 percent of the population is infected with a pathogen, a so-called “herd immunity” has developed. However, the increasing numbers of deaths and modelling studies showed the expected overload of the hospitals. Therefore, most countries decided for a temporary lockdown with the exception of Sweden.
Based on the number of the total population, three times more people died from COVID-19 in Sweden (2679 deaths per 10 million inhabitants) compared to Germany (6848 deaths per 80 million inhabitants). The comparison Sweden versus Taiwan is even worse because 1072 times more people died in Sweden based on the number of the population (6 deaths per 24 million inhabitants).